CULLINAN PEARL
Cullinan Pearl develops an orally available tyrosine kinase inhibitor to target Epidermal Growth Factor Receptor exon 20 mutations. Cullinan Pearl is a subsidiary of Cullinan Oncology.
CULLINAN PEARL
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.cullinanoncology.com
Status:
Active
Total Funding:
0
Investors List
Cullinan Oncology
Cullinan Oncology investment in Series A - Cullinan Pearl
Taiho Ventures
Taiho Ventures investment in Series A - Cullinan Pearl
Official Site Inspections
http://www.cullinanoncology.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 